Bookmark

Add to MyYahoo RSS

Bind Biosciences News

News on Bind Biosciences (Ticker: SGMO) continually updated from thousands of sources around the net.

Yesterday | AmericanBankingNews.com

Insider Selling: Sangamo Biosciences CFO Unloads 15,000 Shares of Stock

Sangamo Biosciences CFO Henry Ward Wolff sold 15,000 shares of the company's stock in a transaction dated Thursday, July 10th.

Comment?

Related Topix: Sangamo Biosciences, Startups

Tue Jul 08, 2014

Customer Interaction Solutions

Analysts Review Releases Notes on Alere, AMRI, Anika Therapeutics,...

On July 4, Analysts Review released its analysts' notes regarding Alere, Albany Molecular Research, Anika Therapeutics, Nektar Therapeutics and Sangamo Biosciences.

Comment?

Related Topix: Biotech, Medicine, Anika Therapeutics, Healthcare Industry, Sangamo Biosciences, Startups, Albany Molecular Research, Nektar Therapeutics

Thu Jul 03, 2014

AmericanBankingNews.com

Sangamo Biosciences SVP Sells $234,900 in Stock

Sangamo Biosciences SVP Philip D. Gregory sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st.

Comment?

Related Topix: Sangamo Biosciences, Startups

Wed Jun 25, 2014

AmericanBankingNews.com

Sangamo Biosciences Director Saira Ramasastry Sells 5,550 Shares

Sangamo Biosciences Director Saira Ramasastry unloaded 5,550 shares of Sangamo Biosciences stock on the open market in a transaction dated Monday, June 23rd.

Comment?

Related Topix: Sangamo Biosciences, Startups

Thu Jun 19, 2014

AmericanBankingNews.com

Sangamo Biosciences CEO Edward O. Lanphier II Sells 25,000 Shares

Sangamo Biosciences CEO Edward O. Lanphier II sold 25,000 shares of the company's stock in a transaction dated Monday, June 16th.

Comment?

Related Topix: Sangamo Biosciences, Startups

AmericanBankingNews.com

Sangamo Biosciences Shares Down 4.5% After Insider Selling

Sangamo Biosciences 's share price dropped 4.5% on Wednesday after an insider sold shares in the company, Stock Ratings Network reports.

Comment?

Related Topix: Sangamo Biosciences, Startups

Tue Jun 17, 2014

Freshnews

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

Sangamo BioSciences, Inc. announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 3:30 pm ET on Tuesday, June 24, 2014, at the 9th Annual JMP Securities Healthcare ... (more)

Comment?

Related Topix: Sangamo Biosciences, Startups, Genetics, Medicine, Infectious Diseases

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••